Completed OBSERVATIONAL NCT03924440

Ovulation Double Check (Proov) Verification and Usability Testing

Characterization and Use of Urine Pregnanediol Rapid Test and Its Use for Confirming Ovulation - Proov (Ovulation Double Check) Test

Sponsor: MFB Fertility

Conditions Ovulation Disorder

Interventions Proov (Ovulation Double Check) Test

Updated 7 times since 2019 Last updated: Mar 17, 2024 Started: Oct 1, 2016 Primary completion: Dec 31, 2021 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03924440, this observational or N/A phase trial focuses on Ovulation Disorder and remains completed. Sponsored by MFB Fertility, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2024 — Jul 2024 [monthly]

Completed

Status: Enrolling By Invitation → Completed
May 2022 — Apr 2024 [monthly]

Enrolling By Invitation
Jan 2021 — May 2022 [monthly]

Enrolling By Invitation

▶ Show 2 earlier versions

Oct 2020 — Jan 2021 [monthly]

Enrolling By Invitation

Status: Active Not Recruiting → Enrolling By Invitation
May 2019 — Oct 2020 [monthly]

Active Not Recruiting

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MFB Fertility

Data source: MFB Fertility

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.